Latest Health News
WHO Expresses Regret Over US Withdrawal from Organization
The World Health Organization regrets the United States' formal notification of withdrawal on January 22, 2026, warning it poses risks to global and US health security. WHO rejects US claims of mishandling COVID-19, emphasizing its swift response from December 2019 alerts and transparent information sharing.
The issue will be reviewed by the WHO Executive Board on February 2 and World Health Assembly in May 2026.
US Officially Exits WHO After Trump's Executive Order
President Trump signed Executive Order 14155 on January 20, 2025, initiating the US withdrawal from WHO, effective January 22, 2026. The US cites WHO's COVID-19 handling, including alleged delays and politicization, as reasons for exit.
WHO hopes for future US re-engagement, highlighting past contributions like smallpox eradication.
WHO Warns US Exit Endangers Global Health Security
WHO states the US withdrawal will make both the US and world less safe, impacting disease surveillance and response. As a founding member, US funding and participation end, weakening global initiatives.
Experts debate long-term effects on vaccine coordination and outbreak preparedness.
New Blood Test Detects Crohn's Disease Years Early
A new blood test identifies Crohn's disease years before symptoms by detecting unusual immune responses to gut bacteria. This early detection could revolutionize management of the inflammatory bowel disease.
Research published January 22, 2026.
Scientists Unlock Weakness in Deadly Drug-Resistant Fungi
After 11 years, McMaster University researchers found butyrolactol A molecule dramatically weakens deadly fungi amid rising resistance. This breakthrough offers new treatment avenues as options stall.
Announced January 22, 2026.
Stanford Develops Cartilage-Regrowing Therapy to Stop Arthritis
Stanford Medicine discovered a treatment blocking an aging protein to reverse cartilage loss and prevent arthritis post-injury. The therapy restores shock-absorbing cartilage in aging joints.
Reported January 20, 2026.
Vagus Nerve Implant Transforms Lives of Treatment-Resistant Depression Patients
Vagus nerve stimulation implant helped patients with long-term depression improve and sustain benefits for at least two years. Many had tried all other treatments without success.
Study results from January 20, 2026.
Breakthrough in Growing Helper T Cells for Cancer Therapy
Researchers solved growing helper T cells from stem cells, boosting immune-based cancer treatments by coordinating immune attacks. This addresses a key roadblock in cancer cell therapy.
Announced January 20, 2026.
FDA Grants Priority Review for Gedatolisib in Advanced Breast Cancer
Gedatolisib showed significant progression-free survival benefits in advanced breast cancer per VIKTORIA-1 trial, earning FDA priority review. This PI3K/mTOR inhibitor advances treatment options.
Recent oncology updates.
Amivantamab Shows Promise in Metastatic Colorectal Cancer
Updated OrigAMI-1 trial data at 2026 ASCO GI Symposium highlight amivantamab with chemo overcoming EGFR inhibitor resistance in metastatic CRC. Achieved notable objective response and PFS rates.
Signals shift beyond first-gen therapies.
FDA Breakthrough Designation for Sofetabart Mipitecan in Ovarian Cancer
Sofetabart mipitecan, a FRα-targeted ADC, receives FDA breakthrough therapy status for platinum-resistant ovarian cancer. Targets unmet needs in advanced disease.
Recent FDA news in oncology.
Antifungal SCY-247 Gets FDA QIDP and Fast Track Amid Resistance Rise
Scynexis' SCY-247 earns FDA Qualified Infectious Disease Product and Fast Track designations to combat rising antifungal resistance. Accelerates development for serious infections.
Announced this past week.